176 related articles for article (PubMed ID: 36473607)
1. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
Wang H; Wu C; Tong X; Chen S
J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
[TBL] [Abstract][Full Text] [Related]
2. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
3. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy.
Zhou J; Hu Y; Cao Y; Ding S; Zeng L; Zhang Y; Cao M; Duan G; Zhang X; Bian XW; Tian G
J Colloid Interface Sci; 2024 Apr; 660():869-884. PubMed ID: 38277843
[TBL] [Abstract][Full Text] [Related]
4. Transforming Cold Tumors into Hot Ones with a Metal-Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy.
Xu M; Chang Y; Zhu G; Zhu X; Song X; Li J
ACS Appl Mater Interfaces; 2023 Apr; 15(14):17470-17484. PubMed ID: 36995264
[TBL] [Abstract][Full Text] [Related]
5. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy.
Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J
Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008
[TBL] [Abstract][Full Text] [Related]
7. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
8. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Immunogenic Cell Death and Antigen Presentation
He T; Wang L; Gou S; Lu L; Liu G; Wang K; Yang Y; Duan Q; Geng W; Zhao P; Luo Z; Cai K
ACS Nano; 2023 Jun; 17(11):9953-9971. PubMed ID: 37212750
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
12. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
13. Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.
Dai Z; Wang Q; Tang J; Wu M; Li H; Yang Y; Zhen X; Yu C
Biomaterials; 2022 Jan; 280():121261. PubMed ID: 34815099
[TBL] [Abstract][Full Text] [Related]
14. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
[TBL] [Abstract][Full Text] [Related]
15. Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy.
Yan WL; Lang TQ; Yuan WH; Yin Q; Li YP
Acta Pharmacol Sin; 2022 Dec; 43(12):3045-3054. PubMed ID: 36050519
[TBL] [Abstract][Full Text] [Related]
16. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
[TBL] [Abstract][Full Text] [Related]
17. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
18. Lactate-Responsive Gene Editing to Synergistically Enhance Macrophage-Mediated Cancer Immunotherapy.
Li Y; Wei Y; Huang Y; Qin G; Zhao C; Ren J; Qu X
Small; 2023 Aug; 19(35):e2301519. PubMed ID: 37156740
[TBL] [Abstract][Full Text] [Related]
19. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody.
Li Z; Cai H; Li Z; Ren L; Ma X; Zhu H; Gong Q; Zhang H; Gu Z; Luo K
Bioact Mater; 2023 Mar; 21():299-312. PubMed ID: 36157245
[TBL] [Abstract][Full Text] [Related]
20. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
